Overview

Bivalirudin in Late PCI for Oatients With STEMI

Status:
Not yet recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Bivalirudin is recomended by guidelines during primary PCI procedure for patients with STEMI. However, there is a large number of STEMI patients who missed the primary PCI. So the investigators aim to study the efficiency and safety of bivalirudin as the anticoagulation therapy during late PCI.
Phase:
Phase 4
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University
Treatments:
Antithrombins
Bivalirudin
Calcium heparin
Heparin
Hirudins
Thrombin